Update on Clostridium difficile infections, M??decine et Maladies Infectieuses, vol.44, issue.8, pp.354-65, 2014. ,
DOI : 10.1016/j.medmal.2014.04.002
Clinical and microbiological features of Clostridium difficile infections in France: The ICD-RAISIN 2009 national survey, M??decine et Maladies Infectieuses, vol.43, issue.2, pp.67-74, 2013. ,
DOI : 10.1016/j.medmal.2013.01.004
Clostridium difficile infection in Europe: a hospital-based survey, The Lancet, vol.377, issue.9759, pp.63-73, 2011. ,
DOI : 10.1016/S0140-6736(10)61266-4
Clostridium difficileassociated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity Severe Clostridium difficile-associated disease in populations previously at low risk-four states, CMAJ. Centers for Disease Control and Prevention MMWR, vol.17154, issue.6, pp.1201-1206, 2004. ,
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection (CDI), Clinical Microbiology and Infection, vol.15, issue.12, pp.1053-66, 2009. ,
DOI : 10.1111/j.1469-0691.2009.03098.x
Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA), Infection Control and Hospital Epidemiology, vol.31, issue.5, pp.431-55, 2010. ,
DOI : 10.1086/651706
European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection, Clinical Microbiology and Infection, vol.20, pp.1-26, 2014. ,
DOI : 10.1111/1469-0691.12418
diagnostic, investigation, surveillance et principes de prévention et de maîtrise des infections à Clostridium difficile. Guide RAISIN, 2006. ,
Infection and Colonization, New England Journal of Medicine, vol.365, issue.18, pp.1693-703, 2011. ,
DOI : 10.1056/NEJMoa1012413
???Associated Diarrhea: This Is an Antimicrobial Resistance Problem, Clinical Infectious Diseases, vol.16, issue.5, pp.646-654, 2004. ,
DOI : 10.1093/jac/46.4.551
Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in Quebec, Clinical Infectious Diseases, vol.118, issue.3, pp.1254-60, 2005. ,
DOI : 10.1016/j.amjmed.2004.09.015
Restriction of third generation cephalosporin use reduces the incidence of Clostridium difficile-associated diarrhoea in hospitalised patients, Commun Dis Intell Q Rep, vol.27, pp.28-31, 2003. ,
Rapport d'élaboration de févier 2014 Rapport d'élaboration -principes généraux et conseils de prescription des antibiotiques en premiers recours ,
infection, Annals of Internal Medicine, vol.157, issue.4, pp.2-13, 2012. ,
DOI : 10.7326/0003-4819-157-4-201208210-02013
Les IPP en EHPAD-l'expérience de l'EPHAD du Dr Chastaing à Limoges, 31ème Journées annuelles de la Société Française de Gériatrie et de Gérontologie, pp.4-6, 2011. ,
Conclusions., Infection Control & Hospital Epidemiology, vol.29, issue.03, pp.197-202, 2008. ,
DOI : 10.1016/S0140-6736(00)03592-3
Conclusion., Infection Control & Hospital Epidemiology, vol.37, issue.02, pp.131-140, 2007. ,
DOI : 10.1099/jmm.0.45610-0
Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease, The American Journal of Gastroenterology, vol.78, issue.7, pp.1769-75, 2002. ,
DOI : 10.1128/IAI.69.4.2762-2765.2001
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection, Journal of Hospital Infection, vol.70, issue.4, pp.298-304, 2008. ,
DOI : 10.1016/j.jhin.2008.08.012
Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada, Clinical Infectious Diseases, vol.171, issue.11, pp.1591-1598, 2005. ,
DOI : 10.1503/cmaj.1041694
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea, The Lancet, vol.357, issue.9251, pp.189-93, 2001. ,
DOI : 10.1016/S0140-6736(00)03592-3
Immunological properties of surface proteins of Clostridium difficile, Journal of Medical Microbiology, vol.54, issue.2, pp.193-199, 2005. ,
DOI : 10.1099/jmm.0.45800-0
Laboratory diagnosis of Clostridium difficile infection, Ann Biol Clin, vol.71, pp.395-400, 2013. ,
Pseudomembranous colitis: Not always Clostridium difficile, Cleveland Clinic Journal of Medicine, vol.83, issue.5, pp.1-4, 2014. ,
DOI : 10.3949/ccjm.83a.14183
A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity, Clinical Infectious Diseases, vol.343, issue.26, pp.302-309, 2007. ,
DOI : 10.1056/NEJM200012283432604
Treatment of Clostridium difficile-associated disease: old therapies and new strategies, The Lancet Infectious Diseases, vol.5, issue.9, pp.549-57, 2005. ,
DOI : 10.1016/S1473-3099(05)70215-2
Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole, Clinical Infectious Diseases, vol.22, issue.3, pp.1586-90, 2005. ,
DOI : 10.1128/IAI.71.3.1608-1610.2003
: response time for treatment with metronidazole and vancomycin, Journal of Antimicrobial Chemotherapy, vol.36, issue.4, pp.673-682, 1995. ,
DOI : 10.1093/jac/36.4.673
Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin, Clinical Infectious Diseases, vol.52, issue.8, pp.154-61, 2012. ,
DOI : 10.1128/AAC.00342-08
Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease, Alimentary Pharmacology & Therapeutics, vol.45, issue.Suppl. 1, pp.865-75, 2012. ,
DOI : 10.1097/MCG.0b013e3182166c8b
Toxins, New England Journal of Medicine, vol.362, issue.3, pp.197-205, 2010. ,
DOI : 10.1056/NEJMoa0907635
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children, Cochrane Database Syst Rev, vol.5, p.6095, 2013. ,
A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease, JAMA, vol.271, 1994. ,
Antibiotic-associated diarrhoea and Clostridium difficile> in the community, Alimentary Pharmacology and Therapeutics, vol.250, issue.7, pp.905-917, 2003. ,
DOI : 10.1016/S0140-6736(00)03592-3